← Leaderboards
Wenshe Ray Liu
Texas A&M University
$8,121,141
Attributed
$8,121,141
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,121,141 · 7
By mechanism
R01$5,214,600 · 4
R35$2,118,659 · 1
R21$787,882 · 2
Top collaborators
No co-investigators on record.
Most similar at Texas A&M University
Same institution · by research overlap
- Frank M. Raushel$17,215,773
- Lakenya F Williams$54,390
- Audrey J Joslin$420,229
- Thomas R Ioerger$250,000
Others in their field
Top investigators on “Mission”
- Kelly K Wismer · Department Of Defense$358,750,224
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$333,898,233
- Michael E Cheney · Department Of Defense$330,315,072
- David Heimbrook · Leidos Biomedical Research, Inc.$325,587,550
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
MissionUnited States National Institutes Of HealthProteinsAmino AcidsModificationSiteCellsSmall MoleculePublic HealthHealth PromotionBaseLysineGeneticPeptidesRegulationHistonesMutagenesisCombatEpigenetic ProcessBindingMalignant NeoplasmsBacteriophagesAmberPharmaceutical Preparations
Grant awards (28)
Use of the Noncanonical Amino Acid Mutagenesis Technique in Combination with Other Approaches to Study Functions of Posttranslational Lysine Modifications in Proteins$519,433
R35 · FY2025 · GM · contact PI
A Multiplatform Approach to Develop ENL-Targeting Molecules as Drug Candidates for Acute Myeloid Leukemia$480,008
R01 · FY2025 · CA · contact PI
Use of the Noncanonical Amino Acid Mutagenesis Technique in Combination with Other Approaches to Study Functions of Posttranslational Lysine Modifications in Proteins$519,433
R35 · FY2024 · GM · contact PI
A Multiplatform Approach to Develop ENL-Targeting Molecules as Drug Candidates for Acute Myeloid Leukemia$476,558
R01 · FY2024 · CA · contact PI
Use of the Noncanonical Amino Acid Mutagenesis Technique in Combination with Other Approaches to Study Functions of Posttranslational Lysine Modifications in Proteins$250,000
R35 · FY2024 · GM · contact PI
Use of the Noncanonical Amino Acid Mutagenesis Technique in Combination with Other Approaches to Study Functions of Posttranslational Lysine Modifications in Proteins$519,433
R35 · FY2023 · GM · contact PI
Development of fluorogenic and chemiluminogenic main protease substrates for cellular and in vivo imaging of SARS-CoV-2$186,572
R21 · FY2023 · EB · contact PI
Targeting the ENL YEATS domain for the development of anti-leukemia agents$169,244
R21 · FY2023 · CA · contact PI
Develop General Methods for the Synthesis of Proteins with Posttranslational Lysine Modifications$334,016
R01 · FY2022 · GM · contact PI
Use of the Noncanonical Amino Acid Mutagenesis Technique in Combination with Other Approaches to Study Functions of Posttranslational Lysine Modifications in Proteins$310,360
R35 · FY2022 · GM · contact PI
Development of fluorogenic and chemiluminogenic main protease substrates for cellular and in vivo imaging of SARS-CoV-2$224,580
R21 · FY2022 · EB · contact PI
Targeting the ENL YEATS domain for the development of anti-leukemia agents$207,486
R21 · FY2022 · CA · contact PI
Develop General Methods for the Synthesis of Proteins with Posttranslational Lysine Modifications$350,805
R01 · FY2021 · GM · contact PI
Develop General Methods for the Synthesis of Proteins with Posttranslational Lysine Modifications$350,805
R01 · FY2020 · GM · contact PI
Studying Reversible Histone Acylations in Nucleosome Contexts$276,317
R01 · FY2020 · GM · contact PI
Develop General Methods for the Synthesis of Proteins with Posttranslational Lysine Modifications$394,016
R01 · FY2019 · GM · contact PI
Studying Reversible Histone Acylations in Nucleosome Contexts$276,772
R01 · FY2019 · GM · contact PI
Studying Reversible Histone Acylations in Nucleosome Contexts$263,998
R01 · FY2018 · GM · contact PI
Studying Reversible Histone Acylations in Nucleosome Contexts$186,066
R01 · FY2018 · GM · contact PI
Studying Reversible Histone Acylations in Nucleosome Contexts$260,594
R01 · FY2017 · GM · contact PI
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids$297,466
R01 · FY2015 · CA · contact PI
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids$13,292
R01 · FY2015 · CA · contact PI
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids$288,542
R01 · FY2014 · CA · contact PI
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids$53,341
R01 · FY2014 · CA · contact PI
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids$279,618
R01 · FY2013 · CA · contact PI
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids$41,699
R01 · FY2013 · CA · contact PI
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids$297,466
R01 · FY2012 · CA · contact PI
Phage Display with Two Genetically Incorporated Noncanonical Amino Acids$293,221
R01 · FY2011 · CA · contact PI